柳叶刀委员会:减轻全球心脏性猝死负担——呼吁多学科行动
尽管心血管医学取得重大进展,心脏性猝死(SCD)每年仍夺去数百万生命,风险预测不完善且缺乏针对心律失常发生的解决方案。复苏策略虽有显著发展,但不同地区和医疗体系下的社区干预与急救系统组织仍需加强。全球多数地区心脏骤停(SCA)存活率仍低于10%。柳叶刀SCD委员会汇集30名国际多学科专家,对当前科学努力进行批判性评估,并提出关键建议以推动科学界与全球社会采取新方向、研究与创新来减轻SCD负担。
要点
- 全球多数地区SCA存活率仍低于10%,委员会认为这一现状不可接受。
- SCD预防需要彻底革新的方法,包括赋予政府和社区项目发展权限的广泛政策变革。
- 需加强不同地点和医疗结构下社区干预与急救系统的组织。
- 委员会强调需制定涵盖SCD预防和治疗各方面的多学科策略。
- 应优先开展国际合作,最大程度利用并连接各研究组织的专长以解决已识别的差距。
适用人群与场景
- 全球范围内SCD/SCA患者及事件后幸存者和死者家属。
研究设计与关键结果
- 柳叶刀SCD委员会由30名国际多学科专家组成,对当前SCD领域的科学努力进行批判性评估。
- 委员会提出关键建议,以挑战、激活并加强科学界和全球社会在减轻SCD负担方面的新方向、研究和创新努力。
证据类型、等级与局限
- 证据类型:柳叶刀委员会报告(专家共识文件)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 委员会呼吁进行广泛政策变革,以赋能政府和社区项目的发展,最大化SCA存活率并全面关注事件后幸存者和死者家属。
- 委员会强调需制定涵盖SCD预防和治疗各方面的多学科策略。
- 委员会建议优先开展国际合作,最大程度利用并连接各研究组织的专长以解决已识别的差距。
指南或共识出处
- 柳叶刀SCD委员会(The Lancet Commission on SCD)报告。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Despite major advancements in cardiovascular medicine, sudden cardiac death (SCD) continues to be an enormous medical and societal challenge, claiming millions of lives every year. Efforts to prevent SCD are hampered by imperfect risk prediction and inadequate solutions to specifically address arrhythmogenesis. Although resuscitation strategies have witnessed substantial evolution, there is a need to strengthen the organisation of community interventions and emergency medical systems across varied locations and health-care structures. With all the technological and medical advances of the 21st century, the fact that survival from sudden cardiac arrest (SCA) remains lower than 10% in most parts of the world is unacceptable. Recognising this urgent need, the Lancet Commission on SCD was constituted, bringing together 30 international experts in varied disciplines. Consistent progress in tackling SCD will require a completely revamped approach to SCD prevention, with wide-sweeping policy changes that will empower the development of both governmental and community-based programmes to maximise survival from SCA, and to comprehensively attend to survivors and decedents' families after the event. International collaborative efforts that maximally leverage and connect the expertise of various research organisations will need to be prioritised to properly address identified gaps. The Commission places substantial emphasis on the need to develop a multidisciplinary strategy that encompasses all aspects of SCD prevention and treatment. The Commission provides a critical assessment of the current scientific efforts in the field, and puts forth key recommendations to challenge, activate, and intensify efforts by both the scientific and global community with new directions, research, and innovation to reduce the burden of SCD worldwide.
参考来源
- Marijon E, Narayanan K, Smith K, et al. The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action. Lancet. 2023. PMID: 37647926. doi:10.1016/S0140-6736(23)00875-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。